ARCHIVES

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: House Fills Subcommittee Positions; Senate Schedules NCI Appropriations Hearing Feb. 18

February 13, 1981

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

House Passes Bill On New Cigarette Labels

September 14, 1984

Holland, Leader Win $250,00 Milken Awards: Six Others Get $50,000 Prizes

December 9, 1988

Clinical Trials Approved By NCI

October 31, 2003

JR Adams Elected President, Ovarian Cancer Coalition.

March 9, 2001